The top money raisers in biotech
The Top Line
Biotech Trends and Investment Strategies
Exploring the rise of dual-track processes in biotech companies, focusing on cutting-edge technologies like AI, RNA editing, and cell therapy for autoimmune diseases. Highlighting the shift towards targeting undrugable diseases and significant financing rounds in areas like neuroscience and cardiovascular breakthroughs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
